Biliary Tract Articles & Analysis
5 news found
Enrollment continues in the phase 1/2a combination study of AFM24 with the anti-PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) (AFM24-102) to treat patients with non-small cell lung cancer (EGFR wildtype), gastric and gastroesophageal junction adenocarcinoma and pancreatic/hepatocellular/biliary tract cancer. Enrollment continues in the phase 1/2a ...
Under this agreement, GI Innovation and AstraZeneca will conduct a clinical trial assessing triplet combination regimen of GI-101, Imfinzi® (durvalumab) and chemotherapy for the treatment of small cell lung cancer, gastric/gastroesophageal junction cancer, biliary tract cancer and triple-negative breast cancer in USA, Australia and South Korea. ...
By measuring the bilirubin level, it is possible to diagnose the presence and degree of diseases such as the liver and biliary tract, so bilirubin was considered an unhealthy substance. Numerous clinicians and scientists have tried to drug bilirubin, but the main reason for their failure is that bilirubin has extremely hydrophobic properties that do not dissolve ...
By measuring the level of bilirubin, the presence and severity of diseases such as liver and biliary tract can be diagnosed, so bilirubin was considered an unfavorable substance. ...
The results showed that bacteria may be a key factor in the occurrence of biliary tract cancer. If you are interested and want to learn more, please visit https://tumomics.creative-proteomics.com/ for more information. ...